Miller Lloyd S
University of California Los Angeles, Division of Dermatology, Center for Health Sciences, Room 52-121, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Adv Dermatol. 2008;24:71-87. doi: 10.1016/j.yadr.2008.09.004.
TLRs have emerged as a major class of PRRs that are involved in detecting invading pathogens in the skin and initiating cutaneous immune responses. TLRs are expressed on many different cell types in the skin, including keratinocytes and Langerhans cells in the epidermis. Each TLR can recognize a different microbial component and there are differences among the TLR signaling pathways, which lead to distinct immune responses against a given pathogen. Certain TLRs have been implicated in the pathogenesis of skin diseases, such as atopic dermatitis, psoriasis, and acne vulgaris. In addition, TLRs have been shown to be important in cutaneous host defense mechanisms against common bacterial, fungal, and viral pathogens in the skin, such as S aureus, C albicans, and HSV. Since the discovery that topical TLR agonists promote antiviral and antitumor immune responses, there has been considerable interest in the development of TLR-based therapies for skin diseases, skin cancer, and infections. Future research involving TLRs in skin will hopefully provide new insights into host defense against skin pathogens and novel therapeutic targets aimed at treating skin disease and skin cancer.
Toll样受体(TLRs)已成为一类主要的模式识别受体(PRRs),参与检测皮肤中入侵的病原体并启动皮肤免疫反应。TLRs在皮肤中的许多不同细胞类型上表达,包括表皮中的角质形成细胞和朗格汉斯细胞。每种TLR可以识别不同的微生物成分,并且TLR信号通路之间存在差异,这导致针对特定病原体产生不同的免疫反应。某些TLR与皮肤病的发病机制有关,如特应性皮炎、银屑病和寻常痤疮。此外,TLRs已被证明在皮肤针对常见细菌、真菌和病毒病原体(如金黄色葡萄球菌、白色念珠菌和单纯疱疹病毒)的宿主防御机制中很重要。自从发现局部TLR激动剂可促进抗病毒和抗肿瘤免疫反应以来,人们对开发基于TLR的皮肤病、皮肤癌和感染治疗方法产生了浓厚兴趣。未来关于皮肤中TLRs的研究有望为宿主抵御皮肤病原体提供新的见解,并为治疗皮肤病和皮肤癌提供新的治疗靶点。